Sunshine Holdings Plc · CSELK:SUN.N0000
Sunshine — Q2 FY2020 Earnings Presentation
18 slides from Sunshine's earnings presentation, Nov 14, 2019
Slide 1: Earnings Presentation 2QFY20
Earnings Presentation 2QFY20 14th November, 2019
Slide 2: Group Performance
Group Performance
Slide 3: Group at a Glance – 2QFY20 [Jul-Sep] Reported
Group at a Glance – 2QFY20 [Jul-Sep] Reported • LKR 5.3bn in Revenue; +0.7 YoY • LKR 657m PAT; +48.5% YoY • PATMI of LKR 398; +70.0% YoY Revenue - 2QFY20 Other, 2% • Healthcare revenue; LKR 2.8bn; +28.2% YoY • Agri revenue; LKR 0.9bn; -42.6% YoY FMCG, 28% ▪ 3.8m kg of palm oil, +3.0% YoY LKR 5.3bn •
Slide 4: Group at a Glance – 2QFY20 Adjusted for HPL Divestment
Group at a Glance – 2QFY20 [Jul-Sep] Adjusted for HPL Divestment • LKR 5.3bn in Revenue; +17.4 YoY • LKR 657m PAT; +26.0% YoY Revenue - 2QFY20 Other, 2% • Healthcare revenue; LKR 2.8bn; +28.2% YoY • Agri revenue; LKR 0.9bn; +7.5% YoY FMCG, 28% ▪ 3.8m kg of palm oil, +3.0% YoY LKR 5.3bn • FMCG revenu
Slide 5: Group Financial Highlights
Group Financial Highlights 1H 1H Growth 2Q 2Q Growth LKR m FY20 FY19 % FY20 FY19 % Revenue 10,539 10,868 -3.0% 5,329 5,294 0.7% EBIT 1,848 1,281 44.3% 937 682 37.4% EBIT Margin 17.5% 11.8% 17.6% 12.9% PAT 1,230 784 56.9% 657 443 48.5% PAT Margin 11.7% 7.2% 12.3% 8.4% PATMI 731 424 72.5% 398 234 70.0
Slide 6: 2Q Revenue Growth Trend
2Q Revenue Growth Trend • 5 Year CAGR of 5% 5 Yr CAGR: 5% 6,000 14% 5,164 5,294 5,329 5,000 4,864 12% 4,341 12% 10% 4,000 LKR m 8% 3,000 6% 6% 2,000 4% 4% 1,000 3% 2% 1% - 0% 2QFY16 2QFY17 2QFY18 2QFY19 2QFY20 Revenue Revenue Growth
Slide 7: 2Q Profitability
2Q Profitability 700 14% 12% 600 11% 12% 11% 500 10% 8% 8% 400 8% LKR m 300 6% 200 4% 100 2% 344 517 588 443 657 - 0% 2QFY16 2QFY17 2QFY18 2QFY19 2QFY20 PAT PAT Margin • Net profit of LKR 657m compared to a profit of LKR443m 2Q last year due to; • Higher performance improve in the Healthcare sector
Slide 8: Segment Performance
Segment Performance
Slide 9: Healthcare
Healthcare 1H 1H Growth 2Q 2Q Growth LKR m FY20 FY19 % FY20 FY19 % Revenue 5,267 4,417 19.2% 2,796 2,181 28.2% EBIT 452 237 90.5% 222 90 147.8% EBIT Margin 8.6% 5.4% 7.9% 4.1% PAT 273 154 77.5% 132 66 99.5% PAT Margin 5.2% 3.5% 4.7% 3.0% Highlights • 2QFY20 Revenue up by 28.2% YoY due to higher sale
Slide 10: Healthcare Retail
Healthcare Retail 22 Outlets existing outlets in Colombo, including 11 express outlets Highlights • Contraction in EBIT margin due to lower foot fall • 2Q revenue growth indicating a strong recovery after Easter Sunday incident • Consumer Curtailed spending on non-essentials • Improve operational ef
Slide 11: FMCG
FMCG 1H 1H Growth 2Q 2Q Growth LKR m FY20 FY19 % FY20 FY19 % Revenue 2,782 2,769 0.5% 1,472 1,378 6.8% EBIT 286 346 -17.3% 201 214 -6.0% EBIT Margin 10.3% 12.5% 13.7% 15.5% PAT 199 236 -15.9% 141 146 -3.4% PAT Margin 7.1% 8.5% 9.6% 10.6% Highlights • 2QFY20 Revenue increase due to Re-launching of br
Slide 12: Agri
Agri 1H 1H Growth 2Q 2Q Growth LKR m FY20 FY19 % FY20 FY19 % Revenue 1,812 1,540 17.6% 932 867 7.5% EBIT 819 628 30.4% 454 418 8.8% EBIT Margin 45.2% 40.8% 48.7% 48.2% PAT 603 478 26.1% 342 328 4.4% PAT Margin 33.3% 31.0% 36.7% 37.8% Excluding Tea plantation business Highlights • Revenue increased b
Slide 13: Energy
Energy 1H 1H Growth 2Q 2Q Growth LKR m FY20 FY19 % FY20 FY19 % Revenue 100 197 -49.4% 74 105 -29.4% EBIT (2) 121 -101.5% 20 66 -69.9% EBIT Margin -1.8% 61.4% 26.7% 62.8% PAT (37) 102 -136.1% 5 58 -90.5% PAT Margin -36.9% 51.8% 7.4% 55.2% Highlights • Revenue decrease by 29.4% YoY due to lower rain f
Slide 14: Additional data for analysts
Additional data for analysts 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q LKR m FY16 FY16 FY17 FY17 FY17 FY17 FY17 FY18 FY18 FY18 FY18 FY19 FY19 FY19 FY19 FY20 FY20 Revenue 4,341 4,288 4,615 4,621 4,864 4,425 5,115 5,164 5,128 5,235 5,618 5,575 5,294 5,792 5,9355 5,210 5,329 PAT 344 391 169 40
Slide 15: Outlook
Outlook
Slide 16: Outlook for 3Q FY20
Outlook for 3Q FY20 Healthcare Agri • Launch new products • Crop to increase with the yield • Strong growth in Medical devices curve shift • Price changes of all pharmaceutical • RSPO audit complete. Certificate products are under the expected in 4Q supervision of NMRA • Increase is milk selling pri
Slide 17: Forward Looking Statements
Forward Looking Statements This presentation contains forward-looking statements that are based on management’s current expectations and assumptions. Forward-looking statements include predictions of future results or activities and may contain the words “expects,” “believes,” “should,” “will,” “ant
Slide 18: Thank you
Thank you For more information, Please visit our Investor Relations page http://www.sunshineholdings.lk/investor%20relations/index.php